Anti-inflammatory Effect of Salvia Miltiorrhiza is Mediated via IL-6, JAK, and STAT Pathway in a Dysfunctional Vascular Endothelial Cell

Download Article

DOI: 10.21522/TIJAR.2014.08.03.Art001

Authors : Emmanuel Adikwu Orgah, Ifeoluwa Margaret Idowu, Mbaoji camilus


The vascular complication of diabetes mellitus is a problem for the patient, and the ability to cope with the disease and the associated inflammation is a critical aspect of diabetes. Cytokines-induced inflammation in vascular endothelial cells (VECs) plays an active role in chronic diseases such as atherosclerosis, diabetes mellitus, kidney injury, and stroke. We investigated the role of total salvianolic acids (TSA), total tanshinones (TTSN), and their combination (TSA/TTSN) on the activated vascular endothelial cell and its inhibitory effect on signal transduction and cytokines regulation. In the extracellular medium of the injury model of human umbilical vein endothelial cells (HUVECs) induced by thrombin, the human IL-6, VCAM-1, and ICAM-1 were significantly elevated (p ˂ 0.05). However, suppression in the TSA, TTSN, and TSA/TTSN (100 µg/L)-treated groups (p > 0.05) were notable. TSA alone but not TTSN and TSA/TTSN combination, inhibited the expression of P-selectin (p < 0.05) and E-selectin (p < 0.01) respectively, in VECs. Western blot analysis showed JAK and STAT expression in VECs however, the protein expression was modest in the Salvia miltiorrhiza-treated groups, indicating the potential of TSA/TTSN in the inflammatory pathways of IL-6, JAK, and STAT signal transduction in endothelial cells (ECs). This study has made novel observations regarding the components of Salvia miltiorrhiza regulatory effect on cytokines in Vascular Biology.


[1] Cahill, P.A., and E.M. Redmond, Vascular endothelium - Gatekeeper of vessel health. Atherosclerosis, 2016. 248: p. 97-109.

[2] Al-Soudi, A., M.H. Kaaij, and S.W. Tas, Endothelial cells: from innocent bystanders to active participants in immune responses. Autoimmunity Reviews, 2017. 16(9): p. 951-962.

[3] Pi, X., L. Xie, and C. Patterson, Emerging Roles of Vascular Endothelium in Metabolic Homeostasis. Circulation Research, 2018. 123(4): p. 477-494.

[4] Mundi, S., et al., Endothelial permeability, LDL deposition, and cardiovascular risk factors—a review. Cardiovascular Research, 2017. 114(1): p. 35-52.

[5] Singh, C., C.G. Pfeifer, and W.A. Jefferies, Pathogenic Angiogenic Mechanisms in Alzheimer’s. Physiologic and Pathologic Angiogenesis: Signaling Mechanisms and Targeted Therapy, 2017: p. 93.

[6] Wolf, D. and K. Ley, Immunity and Inflammation in Atherosclerosis. Circulation Research, 2019. 124(2): p. 315-327.

[7] Nasonov, E.L. and T.V. Popkova, Atherosclerosis: perspectives of anti-inflammatory therapy. Ter Arkh, 2018. 90(5): p. 4-12.

[8] Grandl, G. and C. Wolfrum, Hemostasis, endothelial stress, inflammation, and the metabolic syndrome. Semin Immunopathol, 2018. 40(2): p. 215-224.

[9] Domingueti, C.P., et al., Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability, and vascular complications. Journal of Diabetes and its Complications, 2016. 30(4): p. 738-745.

[10] Tacey, A. et al., The effect of an atherogenic diet and acute hyperglycaemia on endothelial function in rabbits is artery specific. Nutrients, 2020. 12(7): p. 2108.

[11] Cade, W.T., Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther, 2008. 88(11): p. 1322-35.

[12] Palta, S., R. Saroa, and A. Palta, Overview of the coagulation system. Indian Journal of Anaesthesia, 2014. 58(5): p. 515-523.

[13] Göbel, K., et al., The Coagulation Factors Fibrinogen, Thrombin, and Factor XII in Inflammatory Disorders-A Systematic Review. Frontiers in immunology, 2018. 9: p. 1731-1731.

[14] Petrey, A.C., and C.A. de la Motte, Thrombin Cleavage of Inter-α-inhibitor Heavy Chain 1 Regulates Leukocyte Binding to an Inflammatory Hyaluronan Matrix. The Journal of Biological Chemistry, 2016. 291(47): p. 24324-24334.

[15] Wadowski, P.P., et al., Protease-activated receptor-mediated platelet aggregation in acute coronary syndrome patients on potent P2Y(12) inhibitors. Research and practice in thrombosis and haemostasis, 2019. 3(3): p. 383-390.

[16] Orgah, J.O., et al., Pharmacological potential of the combination of Salvia miltiorrhiza (Danshen) and Carthamus tinctorius (Honghua) for diabetes mellitus and its cardiovascular complications. Pharmacological Research, 2020. 153: p. 104654.

[17] Xu, J., et al., Ethnopharmacology, phytochemistry, and pharmacology of Chinese Salvia species: A review. J Ethnopharmacol, 2018. 225: p. 18-30.

[18] Qi, Y., et al., Identification of a Quality Marker (Q-Marker) of Danhong Injection by the Zebrafish Thrombosis Model. Molecules, 2017. 22(9).

[19] Li, G., et al., Comparison of the chromatographic fingerprint, multicomponent quantitation and antioxidant activity of Salvia miltiorrhiza Bge. between sweating and non-sweating. 2018. 32(6): p. e4203.

[20] Luo, H., et al., Quality evaluation of Salvia miltiorrhiza Bge. by ultra-high performance liquid chromatography with photodiode array detection and chemical fingerprinting coupled with chemometric analysis. J Sep Sci, 2015. 38(9): p. 1544-51.

[21] Maione, F. et al., Tanshinone IIA, a major component of Salvia milthorriza Bunge, inhibits platelet activation via the Erk-2 signaling pathway. J Ethnopharmacol, 2014. 155(2): p. 1236-42.

[22] Chen, Z. et al., Tanshinone IIA Exerts Anti-Inflammatory and Immune-Regulating Effects on Vulnerable Atherosclerotic Plaque Partially via the TLR4/MyD88/NF-kappaB Signal Pathway. Front Pharmacol, 2019. 10: p. 850.

[23] Onat, D., et al., Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis. Current diabetes reports, 2011. 11(3): p. 193-202.

[24] Biondi-Zoccai, G.G., et al., Atherothrombosis, inflammation, and diabetes. Journal of the American College of Cardiology, 2003. 41(7): p. 1071-1077.

[25] Bogatcheva, N., J. Garcia, and A. Verin, Molecular mechanisms of thrombin-induced endothelial cell permeability. Biochemistry (Moscow), 2002. 67(1): p. 75-84.

[26] Wagner, D.D. and P.C. Burger, Platelets in inflammation and thrombosis. Arteriosclerosis, thrombosis, and vascular biology, 2003. 23(12): p. 2131-2137.

[27] Gawaz, M., H. Langer, and A.E. May, Platelets in inflammation and atherogenesis. Journal of Clinical Investigation, 2005. 115(12): p. 3378-3384.

[28] Somers, W.S. et al., Insights into the Molecular Basis of Leukocyte Tethering and Rolling Revealed by Structures of P- and E-Selectin Bound to SLeX and PSGL-1. Cell, 2000. 103(3): p. 467-479.

[29] Kontzias, A., et al., Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease. Current Opinion in Pharmacology, 2012. 12(4): p. 464-470.

[30] Bai, K.J., et al., Thrombin-induced CCN2 expression in human lung fibroblasts requires the c-Src/JAK2/STAT3 pathway. J Leukoc Biol, 2013. 93(1): p. 101-12.

[31] Shi, G.P., Immunomodulation of Vascular Diseases: Atherosclerosis and Autoimmunity. European journal of vascular and endovascular surgery: the official journal of the European Society µ for Vascular Surgery, 2010. 39(4): p. 485-494.

[32] Akash, M.S.H., K. Rehman, and S. Chen, Role of inflammatory mechanisms in the pathogenesis of type 2 diabetes mellitus. Journal of cellular biochemistry, 2013. 114(3): p. 525-531.

[33] Tabit, C.E., et al., Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Reviews in Endocrine and Metabolic Disorders, 2010. 11(1): p. 61-74.

[34] Manea, S.-A., A. Manea, and C. Heltianu, Inhibition of JAK/STAT signaling pathway prevents a high-glucose-induced increase in endothelin-1 synthesis in human endothelial cells. Cell and Tissue Research, 2010. 340(1): p. 71-79.

[35] Pigott, R. et al., Soluble forms of E-selectin, ICAM-1, and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochemical and Biophysical Research Communications, 1992. 187(2): p. 584-589.

[36] Jude, E.B., et al., Circulating cellular adhesion molecules ICAM-1, VCAM-1, P- and E-selectin in the prediction of cardiovascular disease in diabetes mellitus. European Journal of Internal Medicine, 2002. 13(3): p. 185-189.

[37] Xie, Z., et al., Dan-Qi prescription ameliorates insulin resistance through overall corrective regulation of glucose and fat metabolism. Journal of ethnopharmacology, 2015. 172: p. 70-79.

[38] Chen, X., et al., Tanshinone II Aattenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation. Oncotarget, 2017. 8(19): p. 31915.